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Abstract 
 
Background: Many patients undergo elective coronary angiography without prior stress testing, 
precluding an assessment of their appropriateness for percutaneous coronary intervention (PCI).  If, 
however, these patients have more severe angina or obstructive coronary artery disease (CAD), 
proceeding directly to angiography would represent efficient resource utilization.  
 
Methods:  We identified patients without a prior history of obstructive CAD undergoing elective 
coronary angiography performed between July 2009 and March 2012 in the NCDR CathPCI 
Registry® and assessed for differences in angina (Canadian Cardiovascular Society [CCS] class) and 
severity of obstructive CAD (>70% stenosis in an epicardial or >50% in a left main coronary artery) 
in those with and without pre-procedural stress testing. Given the large sample size, differences were 
considered clinically meaningful if the standardized difference was >10%.  To further understand 
whether proceeding to coronary angiography without prior stress testing was justified because of a 
high clinical pre-test probability for CAD, we also compared the frequency of obstructive CAD. 
 
Results: Of 403,182 patients undergoing elective coronary angiography, nearly half (49.7%) were 
performed without prior stress testing. Patients without prior stress testing were more frequently 
asymptomatic (CCS class 0), as compared with those who had prior stress testing (40.5% vs. 28.7%; 
standardized difference 19.1%). There were no meaningful differences in the frequency of proximal 
LAD (5.1 % in no stress test group vs. 6.4% in stress test group; standardized difference 5.7%), left 
main (2.9% vs. 3.5%; standardized difference 3.5%) or 3-vessel CAD (4.4% vs. 6.1%; standardized 
difference 6.0%) between the 2 groups.  Moreover, the likelihood of obstructive CAD in patients 
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undergoing coronary angiography without prior stress testing was 18.0%, as compared with 43.0%, 
22.9%, and 12.6% for those with stress testing showing severe, moderate, and mild ischemia. 
 
Conclusion: In elective angiography, proceeding to coronary angiography without prior stress 
testing was not associated with greater symptoms, higher-risk coronary anatomy, nor a greater 
presence of obstructive CAD.  Many angiographic procedures might be avoided with pre-
procedural stress testing. 
 
Keywords: Coronary angiography, appropriateness of care, stress test, stable angina 
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Introduction: 
 
While the American College of Cardiology (ACC) and the American Heart Association (AHA) 
recommend pre-procedural risk stratification in patients with stable angina prior to invasive 
coronary angiography,1 it is commonly performed2 without non-invasive stress testing.3-6 
Clinically, the decision to proceed directly to coronary angiography without prior stress testing 
may be justified if patients have significant symptoms or a more severe obstructive coronary 
artery disease (CAD), in whom percutaneous coronary intervention (PCI) could impact 
symptoms or prognosis. In such circumstances, stress test results might not alter the decision to 
pursue revascularization and would increase the costs of care. 
The importance of understanding current practice patterns of proceeding directly to 
coronary angiography without prior stress testing was underscored by a recent report from the 
National Cardiovascular Data Registry (NCDR) CathPCI Registry®, in which 11.6% of non-
acute PCIs were deemed inappropriate and unlikely to be of clinical benefit to patients.3 In that 
study, more than 1 in 5 non-acute procedures were excluded from the analysis due to absence of 
pre-procedural non-invasive stress testing, which prevented the authors from assigning an 
appropriateness rating.  Whether patients who do not undergo stress testing prior to coronary 
angiography have more severe symptoms, or a greater burden of obstructive CAD, is unknown.7 
To address this current gap in knowledge and better understand the characteristics of 
patients who undergo coronary angiography without prior stress testing, we compared clinical 
characteristics, symptom severity, and the extent of obstructive CAD among patients undergoing 
elective coronary angiography with and without pre-procedural stress testing.  Furthermore, we 
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examined the likelihood of any obstructive CAD in patients who underwent coronary 
angiography without pre-procedural stress testing, as compared with patients having a high-, 
intermediate-, and low-risk stress test result.  
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Methods: 
 
Data Source 
The NCDR CathPCI Registry® is a national registry sponsored by the ACC and the Society for 
Cardiovascular Angiography and Interventions (SCAI).8,9  Briefly, it is a registry of consecutive 
diagnostic coronary angiography and PCI procedures from more than 1000 hospitals in the U.S. 
Detailed information about patient demographics, clinical features, hospital information, pre-
procedural stress testing results and ischemia severity, angiography findings and in-hospital 
complications are abstracted by trained staff at each hospital using standardized data elements 
(available from the CathPCI registry website [http://www.ncdr.com/WebNCDR/elements.aspx]).  
 
Study Population 
Within the NCDR CathPCI Registry®, we identified 2,071,245 coronary angiograms performed 
between July 2009 and March 2012 from hospitals that reported coronary angiography data. We 
chose this time period for analysis, as Version 4 of the data collection form contains information 
noninvasive stress test results and was first introduced in July 2009.  As we were interested in 
examining the use of stress testing in non-acute presentations, we excluded 879,117 procedures 
performed in the setting of acute coronary syndromes (acute myocardial infarction and unstable 
angina), settings in which pre-procedural stress testing would be inappropriate. We further 
excluded procedures performed in the setting of pre-operative evaluation before non cardiac 
surgery (83,370 procedures), cardiomyopathy (84,389 procedures), recent heart failure 
exacerbation (153,712 procedures) and procedures performed in patients with prior history of 
myocardial infarction, PCI or coronary artery bypass graft (188,516 procedures). Moreover, we 
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excluded 111,869 procedures from hospitals that do not report angiography results in patients not 
undergoing PCI, as well as 166,885 procedures in which a stress test was performed but the 
result was unavailable. Our final study cohort was comprised of 403,182 elective coronary 
angiograms from 821 hospitals (Figure 1). 
 
 
Figure 1. Study Cohort 
 
 
Study Outcomes  
Our primary objectives were to determine whether the symptom burden, severity of obstructive 
CAD, and the presence of any obstructive CAD differed between patients who underwent 
elective coronary angiography without prior stress testing and those with a pre-procedural stress 
test.  Symptom burden was assessed using Canadian Cardiovascular Society (CCS) functional 
class for angina.10  To examine differences in the extent and severity of obstructive CAD 
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between the 2 groups, we compared the distribution of 1-, 2-, and 3-vessel obstructive CAD, as 
well as the frequency of obstructive CAD present in the proximal left anterior descending (LAD) 
and left main coronary arteries.  Consistent with prior studies,3, 5 obstructive CAD was defined as 
a ≥50% stenosis of the left main coronary artery or a ≥70% stenosis of a major epicardial or 
branch vessel ≥2.0 mm in diameter.7  Finally, the likelihood of obstructive CAD was defined as 
the proportion of patients undergoing coronary angiography with evidence of obstructive CAD. 
 
Statistical Analysis 
Baseline demographics and clinical characteristics were compared between patients undergoing 
coronary angiography with and without prior stress testing.  Because of the large sample size, 
which could result in statistically significant p-values without clinically relevant differences in 
proportions, differences between groups were evaluated by computing standardized differences 
(differences in group means divided by the common standard deviation) for each covariate.  
Based on prior work, a standardized difference of  >10% was used to define a clinically 
meaningful difference between groups.11 We first examined whether there were clinically 
important differences in the severity of angina and the severity of obstructive CAD between 
patients undergoing coronary angiography with and without pre-procedural stress testing. We 
then compared the likelihood of any obstructive CAD between patients without pre-procedural 
stress testing and those with a high-risk, intermediate-risk, and low-risk stress test.  
Finally, we examined hospital variation in the proportion of patients proceeding directly 
to coronary angiography without prior risk stratification with stress testing.  After creating 
quartiles of the hospitals, based upon the proportion of coronary angiography procedures without 
prior stress testing, we repeated the above analyses and examined whether there were differences 
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in symptom burden, severity of CAD, and the presence of obstructive CAD between those with 
and without stress testing. 
All statistical analyses were performed with SAS 9.2 (SAS Institute, Inc, Cary, NC) or R 
version 2.10.0 (R Foundation for Statistical Computing, Vienna, Austria).  The authors had full 
access to all of the data in the study and take responsibility for the integrity of the data and the 
accuracy of the data analysis. 
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Results: 
 
Of 403,182 elective coronary angiograms, 202,750 (50.3%) were performed with prior 
stress testing and 200,432 (49.7%) without. The mean age of the study cohort was 61.2 + 12.8 
years, 48.9% of patients were men, 85.3% were white, and 70.7% had private health insurance. 
Table 1 compares baseline characteristics between the two groups. There were no differences 
between the two groups with regards to age, sex, race, insurance status or history of DM.   
 
Severity of Angina Symptoms  
Within the cohort, approximately 35% of patients undergoing coronary angiography reported no 
angina (CCS class 0) and only 11.4% reported severe angina (CCS class III or IV). Compared 
with patients having pre-procedural stress testing, those without stress testing were more 
frequently asymptomatic (CCS class 0: 40.5% vs. 28.7%; standardized difference 19.1% across 
the CCS classes) (Table 2).    
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Severity of Obstructive CAD 
There were no differences in the extent of obstructive CAD among patients with and without 
pre-procedural stress tests. Rates of 3-vessel obstructive CAD were 4.4% for those without, as 
compared with 6.1% (standardized difference 6.1%) for those with prior stress testing (Table 2).  
Rates of proximal LAD (5.1% for no stress test group vs. 6.4% for stress test group; standardized 
difference 5.7%) and left main CAD (2.9% for no stress test group vs. 3.5% for stress test group; 
standardized difference 3.5%) were also similar between the 2 groups.   
 
Likelihood of Finding Obstructive CAD on Coronary Angiography 
The likelihood of obstructive CAD on coronary angiography between patients without and with a 
pre-procedural stress test, stratified by severity of ischemia suggested that those without testing 
were not more likely to have a significant lesion. Among the 200,432 patients that did not have 
pre-procedural stress test, 18% (36,146) had evidence of obstructive CAD.  In contrast, the 
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prevalence of significant CAD was 43.0% (8,670/20,183) for patients with a high-risk stress test, 
22.9% (16,068/70,197) for those with an intermediate-risk stress test, and 12.6% 
(14,162/112,370) for those with a low-risk stress test (Figure 2).   
 
 
Figure 2: Diagnostic Yield of Coronary Angiography Stratified by Severity of Ischemia on 
Stress testing 
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Hospital Variation 
There was significant hospital variation in the proportion of elective coronary angiograms without a 
pre-procedural stress test (median hospital rate, 51.2%; inter-quartile range, 40.2% to 64.2%; range 
0% to 95.2%) (Figure 3).  
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Figure 3: Variation in Hospital Rates of Performing Coronary Angiography without Prior 
Stress Test 
  
However, within each quartile, there remained no clinically meaningful differences in angina 
severity or extent of obstructive CAD between patients with and without prior stress testing 
(Supplementary Appendix eTable 1).   
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Discussion: 
 
In this large, contemporary, national sample of patients without a history of obstructive 
CAD undergoing elective coronary angiography, we found that half of patients proceeded 
directly to invasive management without prior stress testing. When comparing patients with pre-
procedural stress testing to those without, we found less pre-procedural angina and no 
differences in obstructive CAD.  Notably, 40% of patients without pre-procedural stress testing 
were asymptomatic and only 12% had severe angina (CCS class III or IV) to support the decision 
to proceed directly to invasive testing and revascularization based upon symptom relief. 
Moreover, finding that the prevalence of obstructive CAD among patients without pre-
procedural stress testing was lower than that for patients with a high-risk or intermediate risk 
stress test result suggests that clinical judgment was not superior to pre-procedural stress testing 
in identifying patients in whom such testing would not have altered the diagnostic or treatment 
strategy.  Collectively, our findings suggest that current practice patterns of proceeding directly 
to coronary angiography without prior stress testing may be premature in some patients. 
 Our study extends the observations of prior studies that described rates of pre-procedural 
stress testing prior to coronary angiography.  For example, Lin et al. found that nearly half of all 
elective PCIs were performed without pre-procedural stress testing.4  As that study was 
performed in an administrative Medicare claims database, however, the authors were not able to 
examine whether patients who proceeded directly to invasive treatment had more severe 
symptoms (e.g., CCS Class III or IV angina) or more severe CAD to justify the decision to 
forego a stress test.  In a prior study of patients within the NCDR CathPCI Registry®, Patel et al. 
reported that 84% of patients had some form of noninvasive assessment prior to diagnostic 
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coronary angiography.5  However, this study included electrocardiographic abnormalities, resting 
echocardiograms, and any form of computed tomography imaging (e.g., coronary calcium 
screening) as part of their definition of noninvasive testing, even though these modalities are not 
typically considered capable of performing noninvasive risk stratification to define the potential 
benefits of revascularization.  Moreover, that study was not able to assess the severity of angina 
or ischemia, as it used a prior version of the CathPCI data collection form that did not contain 
detailed information on CCS angina class and stress testing results.  By leveraging the 
information on new variables that are now included in Version 4 of the NCDR CathPCI 
Registry®, our study was able to assess both pre-procedural angina and the severity of stress 
testing results and found that the decision to proceed directly to coronary angiography for 
elective patients without prior stress testing was not associated with more severe angina 
symptoms or obstructive CAD as compared with patients who underwent pre-procedural stress 
testing.  
 Our study also found that the likelihood of obstructive CAD on coronary angiography in 
patients without prior obstructive CAD and with a high-risk stress test was only 43%. The 
reasons for the low likelihood rates are unknown but may be due to 1) our intentional restriction 
of the study population to those without known CAD (i.e., patients with prior obstructive CAD, 
myocardial infarction, and coronary revascularization were excluded), 2) inconsistent or lack of 
reporting standards for ischemia risk across sites, and 3) limitations of the prognostic value of 
detecting ischemia on stress testing.  As assessments of ischemia risk are important components 
of appropriate use criteria for diagnostic coronary angiography and coronary revascularization, 
future studies are needed to assess the whether the low predictive value for stress testing 
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observed in our study is due to the lack of rigorous standards among operators and hospitals in 
reporting ischemia risk or other intrinsic limitations of noninvasive ischemia risk evaluation.  
Our study also provides important insights into the patients who were excluded from 
recent evaluations of the appropriateness of PCI in the U.S. due to lack of pre-procedural stress 
testing.3, 12-13  In these prior reports, there were some concern that the exclusion of these patients 
may have led to an overestimation of the inappropriate PCI rate in non-acute settings, especially 
if patients undergoing PCI without pre-procedural stress testing had more severe angina 
symptoms and CAD than those with pre-procedural stress testing.  Our findings do not support 
this concern and may suggest the contrary—that patients who proceed to invasive management 
without pre-procedural stress testing do not have more severe angina or higher-risk coronary 
anatomy and thus may have PCIs which are even less appropriate than those with stress tests 
who were included in the appropriateness assessments.    
Finally, we found that ~90% of patients without pre-procedural stress testing did not have 
severe angina to justify the decision to proceed without prior stress testing. Although it remains 
unclear which clinical factors, in the absence of severe angina, prompted physicians to pursue 
invasive coronary angiography without prior non-invasive stress testing, such practice raises 
questions about deviations from current ACC/AHA/SCAI guidelines,14 which recommend risk 
stratification (non-invasive imaging or other modalities) in elective patients prior to non-acute 
PCIs—a strategy shown to be cost effective 15-17 and associated with improved outcomes.18   
Our study should only be interpreted in the context of the following potential limitations. 
First, hospital participation in the NCDR® CathPCI registry is voluntary, and our results may not 
be generalizable to non-NCDR hospitals.  However, our findings were derived from data at over 
1000 U.S. hospitals and provide the first large-scale, detailed study on characteristics of patients 
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undergoing elective coronary angiography without pre-procedural stress testing.  Second, our 
study excluded patients with acute myocardial infarctions and unstable angina, as the decision to 
proceed without pre-procedural stress testing may be justified in these setting where few clinical 
scenarios are considered inappropriate. We also excluded patients with history of 
cardiomyopathy, recent heart failure exacerbation or prior history of CAD, PCI or CABG, since 
the clinical indications for angiography and revascularization in the former 2 scenarios may not 
be based upon symptoms or CAD severity.  Third, our study used CCS class to assess angina 
severity, which is not patient-reported and may result in some mis-classification of patients’ true 
symptom status.  However, the CCS class is commonly employed in routine practice and 
assessments of appropriate use of PCI; moreover, any misclassification of CCS class would be 
expected to be non-differential.  Fourth, our study did not exclude patients who underwent 
coronary angiography according to pre-specified protocols (e.g. patients with heart transplant) 
since the NCDR does not collect the data necessary to identify such patients. However, these 
scenarios should represent a small minority of the examined studies.  Finally, the reasons for 
foregoing risk stratification with non-invasive stress testing were not collected by the NCDR 
CathPCI registry.  Therefore, we were unable to provide insights as to which patient and 
physician factors influenced the decision to proceed directly to angiography in the absence of 
severe angina symptoms or stress testing.   
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Conclusion: 
 
In this large national study, we found that nearly half of the patients undergoing elective 
coronary angiography did not have pre-procedural risk stratification with non-invasive stress 
testing, despite the fact that most lacked severe angina.  Compared with patients undergoing 
elective coronary angiography with pre-procedural stress testing, those without pre-procedural 
stress testing did not have more severe symptoms or higher-risk CAD. We also found that the 
rates of any obstructive CAD were similar between those with and without pre-procedural stress 
testing and that the lower-than-expected value of ischemic stress testing to identify obstructive 
CAD may warrant additional quality improvement efforts to improve the consistency and value 
of these tests. Nevertheless, our findings suggest that current practice patterns of proceeding 
directly to invasive management without stress testing may be premature in some patients. 
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